Overview
Dr. Edward A. Nardell is a physician at Brigham and Women’s Hospital (BWH). He is also an associate professor in the Departments of Medicine, Environmental Health and Immunology and Infectious Diseases at Harvard Medical School.He received his medical degree from Drexel University College of Medicine. He then completed a residency at Hahnemann University Hospital, followed by fellowships in pulmonary disease at Massachusetts General Hospital and Boston Medical Center (formerly Boston University Medical Center). He is board certified in internal medicine and pulmonary disease.The author of over 110 peer-reviewed publications, Dr. Nardell is a prominent researcher of multidrug resistant tuberculosis (MDR-TB), with a particular focus on airborne TB transmission and control. He is currently studying the transmission of MDR-TB and the effectiveness of various control interventions in several research projects funded by the National Institute of Occupational Safety and Health. He is also involved in a 5-year Fogarty Innovation Grant that uses new technological approaches to airborne infection control to train architects, engineers and physicians in air disinfection research in Peru, South Africa, and other high-burden countries. He is actively developing more efficient and inexpensive ultraviolet germicidal irradiation fixtures and a new environmentally-safe chemical vapor that may reduce airborne transmission. Dr. Nardell has served as president of both the Massachusetts Thoracic Society and the International Union Against Tuberculosis and Lung Disease (IUATLD), North American Region. He is also the incoming chair of the IUATLD Tuberculosis Section, Paris, and the recipient of the Chadwick Medal of the Massachusetts Thoracic Society.
His clinical expertise encompasses Nontuberculous Mycobacterial Lung Disease.
Dr. Nardell is board certified in Pulmonary Disease and Internal Medicine. He is actively involved in clinical research, co-authoring 60 peer reviewed articles and participating in 1 clinical trial. Dr. Nardell is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
15 Francis Street, 2nd Floor, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Dr. Edwin Kepner Silverman is chief of the Channing Division of Network Medicine and a physician at Brigham and Women’s Hospital (BWH). He is also a professor of medicine at Harvard Medical School.He received his medical degree from Washington University School of Medicine. He then completed a residency in internal medicine and a fellowship in pulmonary disease at BWH. He is board certified in critical care medicine and pulmonary medicine.Dr. Silverman’s clinical interests include alpha 1-antitrypsin deficiency, emphysema, pulmonary fibrosis and chronic obstructive pulmonary disease (COPD). He has served as a principal investigator of multiple COPD genetics studies funded by the National Institutes of Health, including the NETT Genetics Ancillary Study, the Transcontinental COPD Genetics Study, the Alpha-1 Antitrypsin Genetic Modifiers Study and the COPDGene Study. His research uses a variety of genetic analysis approaches to investigate the genetic influences of complex lung diseases, including integrative genomics, linkage analysis, familial aggregation analysis, rare variant analysis and epigenetic studies. He has authored over 320 peer-reviewed publications and is the recipient of the BWH Kenneth L. Baughman Faculty Mentoring Award. Dr. Silverman is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Emphysema, Pulmonary Fibrosis, and Respiratory Syncytial Virus (RSV) Infection. Dr. Silverman is currently accepting new patients.
Massachusetts General Hospital
Erik Folch is an Intensive Care Medicine provider practicing medicine in Boston, Massachusetts. Dr. Folch is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Lung Nodules, ALK-Positive Non-Small Cell Lung Cancer, Emphysema, Advanced Bronchoscopy, and Endoscopy. Dr. Folch is currently accepting new patients.
Brigham And Women's Hospital, Lung Center
Dr. Hisashi Tsukada is a thoracic surgeon at Brigham and Women’s Hospital. He is also an assistant professor in surgery at Harvard Medical School. He received his medical degree and a PhD in medicine from St. Marianna University School of Medicine (Kawasaki, Japan). He then completed a residency in surgery at Mitsui Memorial Hospital (Tokyo). His fellowships include thoracic surgery at St. Marianna University Hospital, thoracic surgery research at Beth Israel Deaconess Medical Center and interventional pulmonology at St. Elizabeth’s Medical Center. Dr. Tsukada specializes in Interventional Pulmonology and his clinical interests concentrate on aligning his research investigations to disease processes he has observed in patients as a practicing thoracic surgeon for more than ten years in Japan. Dr. Tsukada started his service at Brigham and Women’s Hospital in October 2014. He has expanded the Interventional Pulmonology procedures up to 1,000 cases per year in 2023. Dr. Tsukada is research focuses on developing an artificial trachea for in vivo implantation and airway tissue regeneration. He has authored 30 peer-reviewed publications. Dr. Tsukada is fluent in Japanese. Dr. Tsukada is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Lung Nodules, Lymphofollicular Hyperplasia, Mesothelioma, Advanced Bronchoscopy, and Endoscopy. Dr. Tsukada is board certified in Bronchology & Interventional Pulmonology. Dr. Tsukada is currently accepting new patients.
Frequently Asked Questions about Dr. Edward A. Nardell
How do I make an appointment with Dr. Edward A. Nardell?
You can book an appointment with Dr. Edward A. Nardell by calling their office at 617-521-3368. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Edward A. Nardell a top-rated expert for Nontuberculous Mycobacterial Lung Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Edward A. Nardell is classified as an Experienced expert for Nontuberculous Mycobacterial Lung Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Edward A. Nardell specialize in?
While Dr. Edward A. Nardell is a Intensive Care Medicine, they have specific expertise in Nontuberculous Mycobacterial Lung Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Intensive Care Medicine.
Does Dr. Edward A. Nardell participate in research or clinical trials?
Yes. Dr. Edward A. Nardell has published 60 articles and abstracts on conditions like Nontuberculous Mycobacterial Lung Disease. You can view a list of Dr. Edward A. Nardell's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Edward A. Nardell accept my insurance?
Dr. Edward A. Nardell accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 617-521-3368 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Nontuberculous Mycobacterial Lung DiseaseDr. Nardell isExperienced. Learn about Nontuberculous Mycobacterial Lung Disease.

